ÂÜÀòÂÒÂ×

Tomasz Skrzypczak has a strong background in the pharmaceutical sector, currently serving as the Vice President Global Commercial Strategy and Organization at Miltenyi Biomedicine. Tomasz has extensive experience in various roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Symphar Sp.z o.o. Their responsibilities include developing and executing global commercialization and launch strategies for CAR-T therapies, managing global commercial structures, and building digital solutions for CAR-T treatment pathways.